Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey N Weitzel

Showing results (71-80 of 220) with videos related to

Pageof 22
Sort By:
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|September 28, 2018
Experience Gained from the Development and Execution of a Multidisciplinary Multi-syndrome Hereditary Colon Cancer Family ConferenceIlana Solomon, Christina Rybak, Lily Van Tongeren, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 25, 2007
Evidence for common ancestral origin of a recurring BRCA1 genomic rearrangement identified in high-risk Hispanic familiesJeffrey N Weitzel, Veronica I Lagos, Josef S Herzog, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 2009
Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutationsKelly D Gonzalez, Katie A Noltner, Carolyn H Buzin, et al.
Genetics in Medicine Open|December 23, 2024
Addressing the need for genetic cancer risk assessment in Mexico: From establishment of a formal program to delivery innovation and expansionYanin Chávarri-Guerra, José Luis Rodríguez-Olivares, Alfredo Ramírez-González, et al.
Menopause (New York, N.Y.)|October 24, 2019
Does preventive oophorectomy increase the risk of depression in BRCA mutation carriers?Joanne Kotsopoulos, Jacek Gronwald, Jan Lubinski, et al.
JAMA Oncology|October 28, 2021
Analysis of the Li-Fraumeni Spectrum Based on an International Germline TP53 Variant Data Set: An International Agency for Research on Cancer TP53 Database AnalysisChristian P Kratz, Claire Freycon, Kara N Maxwell, et al.
JAMA Network Open|July 2, 2020
Association of a Polygenic Risk Score With Breast Cancer Among Women Carriers of High- and Moderate-Risk Breast Cancer GenesShannon Gallagher, Elisha Hughes, Susanne Wagner, et al.
Briefings in Bioinformatics|September 12, 2015
Collaborative science in the next-generation sequencing era: a viewpoint on how to combine exome sequencing data across sites to identify novel disease susceptibility genesSteven N Hart, Kara N Maxwell, Tinu Thomas, et al.
Cancer|September 20, 2014
Significant clinical impact of recurrent BRCA1 and BRCA2 mutations in MexicoCynthia Villarreal-Garza, Rosa María Alvarez-Gómez, Carlos Pérez-Plasencia, et al.
Breast Cancer Research and Treatment|March 7, 2012
Breast cancer phenotype in women with TP53 germline mutations: a Li-Fraumeni syndrome consortium effortSerena Masciari, Deborah A Dillon, Michelle Rath, et al.
Pageof 22

Showing results (71-80 of 220) with videos related to

Sort By:
Pageof 22
Journal of Cancer Education : the Official Journal of the American Association for Cancer Education|September 28, 2018
Experience Gained from the Development and Execution of a Multidisciplinary Multi-syndrome Hereditary Colon Cancer Family ConferenceIlana Solomon, Christina Rybak, Lily Van Tongeren, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 25, 2007
Evidence for common ancestral origin of a recurring BRCA1 genomic rearrangement identified in high-risk Hispanic familiesJeffrey N Weitzel, Veronica I Lagos, Josef S Herzog, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 11, 2009
Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutationsKelly D Gonzalez, Katie A Noltner, Carolyn H Buzin, et al.
Genetics in Medicine Open|December 23, 2024
Addressing the need for genetic cancer risk assessment in Mexico: From establishment of a formal program to delivery innovation and expansionYanin Chávarri-Guerra, José Luis Rodríguez-Olivares, Alfredo Ramírez-González, et al.
Menopause (New York, N.Y.)|October 24, 2019
Does preventive oophorectomy increase the risk of depression in BRCA mutation carriers?Joanne Kotsopoulos, Jacek Gronwald, Jan Lubinski, et al.
JAMA Oncology|October 28, 2021
Analysis of the Li-Fraumeni Spectrum Based on an International Germline TP53 Variant Data Set: An International Agency for Research on Cancer TP53 Database AnalysisChristian P Kratz, Claire Freycon, Kara N Maxwell, et al.
JAMA Network Open|July 2, 2020
Association of a Polygenic Risk Score With Breast Cancer Among Women Carriers of High- and Moderate-Risk Breast Cancer GenesShannon Gallagher, Elisha Hughes, Susanne Wagner, et al.
Briefings in Bioinformatics|September 12, 2015
Collaborative science in the next-generation sequencing era: a viewpoint on how to combine exome sequencing data across sites to identify novel disease susceptibility genesSteven N Hart, Kara N Maxwell, Tinu Thomas, et al.
Cancer|September 20, 2014
Significant clinical impact of recurrent BRCA1 and BRCA2 mutations in MexicoCynthia Villarreal-Garza, Rosa María Alvarez-Gómez, Carlos Pérez-Plasencia, et al.
Breast Cancer Research and Treatment|March 7, 2012
Breast cancer phenotype in women with TP53 germline mutations: a Li-Fraumeni syndrome consortium effortSerena Masciari, Deborah A Dillon, Michelle Rath, et al.
Pageof 22